Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function

Published:2017-12-12 Issue:2 Volume:10 Page:290-303
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Popp Oliver¹,Moser Samuel²,Zielonka Jörg²,Rüger Petra¹^ORCID,Hansen Silke¹,Plöttner Oliver¹^ORCID

Affiliation:

1. Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Nonnenwald 2, Penzberg, Germany

2. Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Zurich, Wagistrasse 18, Schlieren, Switzerland

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2017.1405203

Reference52 articles.

1. Isotype and glycoform selection for antibody therapeutics

2. Advances in the assessment and control of the effector functions of therapeutic antibodies

3. The Current Status and Prospects of Antibody Engineering for Therapeutic Use: Focus on Glycoengineering Technology

4. Marketed therapeutic antibodies compendium

5. Antibodies to watch in 2014

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omics and CRISPR in CHO bioproduction: a state-of-the-art review;Biotechnology and Bioprocess Engineering;2024-03-29

2. Recent advances in antibody glycoengineering for the gain of functions;Current Opinion in Chemical Biology;2024-02

3. Bioengineering for Production of Biologically Active Compounds in Plants;Biosynthesis of Natural Products in Plants;2024

4. Optimizing effector functions of monoclonal antibodies via tailored N-glycan engineering using a dual landing pad CHO targeted integration platform;Scientific Reports;2023-09-20

5. Strategies for controlling afucosylation in monoclonal antibodies during upstream manufacturing;Biotechnology Journal;2023-04-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3